GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf12
|
ENSRNOG00000009145 | Kruppel-like factor 12 |
Klf14
|
ENSRNOG00000027557 | Kruppel-like factor 14 |
Sp4
|
ENSRNOG00000005472 | Sp4 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf12 | rn6_v1_chr15_-_84676125_84676125 | -0.47 | 1.2e-18 | Click! |
Klf14 | rn6_v1_chr4_-_58250798_58250798 | -0.20 | 3.9e-04 | Click! |
Sp4 | rn6_v1_chr6_-_146195819_146195819 | -0.04 | 5.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_12227010 | 60.79 |
ENSRNOT00000060843
ENSRNOT00000092610 |
Baiap2l1
|
BAI1-associated protein 2-like 1 |
chr2_+_77868412 | 49.85 |
ENSRNOT00000065897
ENSRNOT00000014022 |
Myo10
|
myosin X |
chr1_+_103172987 | 38.62 |
ENSRNOT00000018688
|
Tmem86a
|
transmembrane protein 86A |
chr1_-_80544825 | 37.40 |
ENSRNOT00000057802
ENSRNOT00000040060 ENSRNOT00000067049 ENSRNOT00000052387 ENSRNOT00000073352 |
Relb
|
RELB proto-oncogene, NF-kB subunit |
chr3_-_14538241 | 37.04 |
ENSRNOT00000025904
|
Stom
|
stomatin |
chr20_+_13799102 | 35.53 |
ENSRNOT00000001669
|
Gstt1
|
glutathione S-transferase theta 1 |
chr12_+_2180150 | 31.68 |
ENSRNOT00000001322
|
Stxbp2
|
syntaxin binding protein 2 |
chr1_-_142615673 | 30.80 |
ENSRNOT00000018021
|
Iqgap1
|
IQ motif containing GTPase activating protein 1 |
chr8_+_5967463 | 30.46 |
ENSRNOT00000086251
|
Tmem123
|
transmembrane protein 123 |
chr19_-_37370429 | 29.05 |
ENSRNOT00000022497
|
Kctd19
|
potassium channel tetramerization domain containing 19 |
chr1_-_78212350 | 28.67 |
ENSRNOT00000071098
|
Inafm1
|
InaF-motif containing 1 |
chr15_+_40937708 | 28.53 |
ENSRNOT00000018407
|
Spata13
|
spermatogenesis associated 13 |
chr10_-_40525008 | 27.91 |
ENSRNOT00000016440
|
Slc36a2
|
solute carrier family 36 member 2 |
chr13_+_34610684 | 27.17 |
ENSRNOT00000093019
ENSRNOT00000003280 |
Tfcp2l1
|
transcription factor CP2-like 1 |
chr20_-_3397039 | 26.50 |
ENSRNOT00000001084
ENSRNOT00000085259 |
Ppp1r18
|
protein phosphatase 1, regulatory subunit 18 |
chr5_+_155812105 | 26.32 |
ENSRNOT00000039341
|
AABR07073181.1
|
|
chr14_-_1461543 | 25.82 |
ENSRNOT00000075656
|
Crlf2
|
cytokine receptor-like factor 2 |
chr10_-_105600913 | 24.69 |
ENSRNOT00000068026
|
Rhbdf2
|
rhomboid 5 homolog 2 |
chr12_+_16988136 | 24.55 |
ENSRNOT00000078925
ENSRNOT00000036744 |
Micall2
|
MICAL-like 2 |
chr16_+_48863418 | 24.23 |
ENSRNOT00000029868
|
Primpol
|
primase and DNA directed polymerase |
chr9_-_78369031 | 24.00 |
ENSRNOT00000087870
|
Bard1
|
BRCA1 associated RING domain 1 |
chr1_+_256745288 | 23.36 |
ENSRNOT00000022133
|
Cep55
|
centrosomal protein 55 |
chr14_-_84662143 | 23.21 |
ENSRNOT00000057529
ENSRNOT00000080078 |
Hormad2
|
HORMA domain containing 2 |
chr1_+_142034423 | 21.43 |
ENSRNOT00000090006
|
Ttll13
|
tubulin tyrosine ligase-like family, member 13 |
chr4_-_81968832 | 21.04 |
ENSRNOT00000016608
|
Skap2
|
src kinase associated phosphoprotein 2 |
chr16_+_74752655 | 20.85 |
ENSRNOT00000029266
|
Ckap2
|
cytoskeleton associated protein 2 |
chr12_-_18540166 | 20.84 |
ENSRNOT00000001792
|
Il3ra
|
interleukin 3 receptor subunit alpha |
chr5_-_57168610 | 20.60 |
ENSRNOT00000090499
|
B4galt1
|
beta-1,4-galactosyltransferase 1 |
chr4_+_79021872 | 20.34 |
ENSRNOT00000012677
ENSRNOT00000067125 |
Fam221a
|
family with sequence similarity 221, member A |
chr5_-_76756140 | 20.19 |
ENSRNOT00000022107
ENSRNOT00000089251 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr1_-_47213749 | 19.99 |
ENSRNOT00000024656
|
Dynlt1
|
dynein light chain Tctex-type 1 |
chr13_+_49092306 | 19.65 |
ENSRNOT00000000039
|
Nuak2
|
NUAK family kinase 2 |
chr1_+_85162452 | 19.28 |
ENSRNOT00000093347
|
Pak4
|
p21 (RAC1) activated kinase 4 |
chr1_-_87221826 | 19.15 |
ENSRNOT00000046611
ENSRNOT00000028006 |
Spint2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr9_+_112293388 | 19.12 |
ENSRNOT00000020767
|
Man2a1
|
mannosidase, alpha, class 2A, member 1 |
chr2_-_112831476 | 18.55 |
ENSRNOT00000018055
|
Ect2
|
epithelial cell transforming 2 |
chr3_-_3890758 | 18.39 |
ENSRNOT00000064083
|
Sec16a
|
SEC16 homolog A, endoplasmic reticulum export factor |
chr12_+_40244081 | 18.37 |
ENSRNOT00000030583
|
Sh2b3
|
SH2B adaptor protein 3 |
chr1_-_89329185 | 18.31 |
ENSRNOT00000078284
|
Cd22
|
CD22 molecule |
chr7_-_23594133 | 17.91 |
ENSRNOT00000005746
|
Timp3
|
TIMP metallopeptidase inhibitor 3 |
chr1_-_89329418 | 17.81 |
ENSRNOT00000033155
|
Cd22
|
CD22 molecule |
chr19_+_38039729 | 17.66 |
ENSRNOT00000089783
|
Nfatc3
|
nuclear factor of activated T-cells 3 |
chr9_-_78368777 | 17.65 |
ENSRNOT00000020414
|
Bard1
|
BRCA1 associated RING domain 1 |
chr2_+_165601007 | 17.30 |
ENSRNOT00000013931
|
Smc4
|
structural maintenance of chromosomes 4 |
chr8_-_22874637 | 16.82 |
ENSRNOT00000064551
ENSRNOT00000090424 |
Dock6
|
dedicator of cytokinesis 6 |
chr1_+_167309051 | 16.79 |
ENSRNOT00000055235
ENSRNOT00000076894 |
Pgap2
|
post-GPI attachment to proteins 2 |
chr8_-_22821397 | 16.54 |
ENSRNOT00000045488
|
Kank2
|
KN motif and ankyrin repeat domains 2 |
chr1_-_82266727 | 16.44 |
ENSRNOT00000027910
|
Lipe
|
lipase E, hormone sensitive type |
chr4_-_56493923 | 16.41 |
ENSRNOT00000027173
|
Impdh1
|
inosine monophosphate dehydrogenase 1 |
chr12_-_16934706 | 16.35 |
ENSRNOT00000001720
|
Mafk
|
MAF bZIP transcription factor K |
chr19_+_15195565 | 16.30 |
ENSRNOT00000090865
ENSRNOT00000078874 |
Ces1d
|
carboxylesterase 1D |
chr1_+_221448661 | 16.10 |
ENSRNOT00000072493
|
LOC100910252
|
sororin-like |
chr7_-_12673659 | 16.08 |
ENSRNOT00000091650
ENSRNOT00000041277 ENSRNOT00000044865 |
Ptbp1
|
polypyrimidine tract binding protein 1 |
chr3_+_170354141 | 15.73 |
ENSRNOT00000005901
|
Fam210b
|
family with sequence similarity 210, member B |
chr19_+_38039564 | 15.73 |
ENSRNOT00000087491
|
Nfatc3
|
nuclear factor of activated T-cells 3 |
chr1_-_32140136 | 15.64 |
ENSRNOT00000081339
ENSRNOT00000022635 |
Slc12a7
|
solute carrier family 12 member 7 |
chr7_+_12043794 | 15.64 |
ENSRNOT00000039813
|
Atp8b3
|
ATPase phospholipid transporting 8B3 |
chr8_+_122789453 | 15.59 |
ENSRNOT00000014585
|
Cmtm6
|
CKLF-like MARVEL transmembrane domain containing 6 |
chr14_+_34727623 | 15.34 |
ENSRNOT00000071405
ENSRNOT00000090183 |
Kdr
|
kinase insert domain receptor |
chr10_+_106812739 | 15.33 |
ENSRNOT00000074225
|
Syngr2
|
synaptogyrin 2 |
chr1_+_31967978 | 15.28 |
ENSRNOT00000081471
ENSRNOT00000021532 |
Trip13
|
thyroid hormone receptor interactor 13 |
chr3_-_47025128 | 15.24 |
ENSRNOT00000011682
|
Rbms1
|
RNA binding motif, single stranded interacting protein 1 |
chr20_-_45260119 | 15.22 |
ENSRNOT00000000718
|
Slc16a10
|
solute carrier family 16 member 10 |
chr2_-_202816562 | 15.21 |
ENSRNOT00000020401
|
Fam46c
|
family with sequence similarity 46, member C |
chr4_+_157612536 | 15.19 |
ENSRNOT00000055970
|
Chd4
|
chromodomain helicase DNA binding protein 4 |
chr5_-_33182147 | 15.06 |
ENSRNOT00000080358
|
Maged2
|
MAGE family member D2 |
chr1_-_221041401 | 15.04 |
ENSRNOT00000064136
|
Pcnx3
|
pecanex homolog 3 (Drosophila) |
chr14_-_7384876 | 15.02 |
ENSRNOT00000086694
|
Aff1
|
AF4/FMR2 family, member 1 |
chr8_+_62341613 | 14.94 |
ENSRNOT00000066923
|
Scamp2
|
secretory carrier membrane protein 2 |
chr17_-_43614844 | 14.93 |
ENSRNOT00000023054
|
Hist1h1a
|
histone cluster 1 H1 family member a |
chr9_-_27192135 | 14.91 |
ENSRNOT00000017592
|
Tram2
|
translocation associated membrane protein 2 |
chr4_-_123713319 | 14.84 |
ENSRNOT00000012875
ENSRNOT00000086982 |
Slc6a6
|
solute carrier family 6 member 6 |
chr16_+_20426566 | 14.77 |
ENSRNOT00000026225
|
Ifi30
|
IFI30, lysosomal thiol reductase |
chr1_+_199655660 | 14.76 |
ENSRNOT00000027032
|
Armc5
|
armadillo repeat containing 5 |
chr14_+_34727915 | 14.65 |
ENSRNOT00000085089
|
Kdr
|
kinase insert domain receptor |
chr2_+_122877286 | 14.52 |
ENSRNOT00000033080
|
Arse
|
arylsulfatase E |
chr19_+_26106838 | 14.50 |
ENSRNOT00000035987
|
Hook2
|
hook microtubule-tethering protein 2 |
chr1_+_263367266 | 14.45 |
ENSRNOT00000054714
|
Nkx2-3
|
NK2 homeobox 3 |
chr1_+_78710539 | 14.38 |
ENSRNOT00000021455
|
Slc1a5
|
solute carrier family 1 member 5 |
chr3_-_2136936 | 14.28 |
ENSRNOT00000010169
|
Arrdc1
|
arrestin domain containing 1 |
chr5_+_105230580 | 14.28 |
ENSRNOT00000010056
|
Acer2
|
alkaline ceramidase 2 |
chr1_+_31835000 | 14.23 |
ENSRNOT00000020780
|
Cep72
|
centrosomal protein 72 |
chr3_-_160802433 | 14.13 |
ENSRNOT00000076191
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr13_-_95943761 | 13.92 |
ENSRNOT00000005961
|
Adss
|
adenylosuccinate synthase |
chr5_-_107857320 | 13.72 |
ENSRNOT00000008898
|
Cdkn2b
|
cyclin-dependent kinase inhibitor 2B |
chr7_-_3132457 | 13.45 |
ENSRNOT00000031963
|
Cdk2
|
cyclin dependent kinase 2 |
chr15_-_51839341 | 13.45 |
ENSRNOT00000011277
|
RGD1308117
|
similar to 9930012K11Rik protein |
chr3_-_119611136 | 13.41 |
ENSRNOT00000016157
|
Ncaph
|
non-SMC condensin I complex, subunit H |
chr1_+_218632764 | 13.14 |
ENSRNOT00000019861
|
Tesmin
|
testis expressed metallothionein like protein |
chr5_-_151824633 | 12.94 |
ENSRNOT00000043959
|
Sfn
|
stratifin |
chr6_+_43829945 | 12.85 |
ENSRNOT00000086548
|
Klf11
|
Kruppel-like factor 11 |
chr1_-_19376301 | 12.78 |
ENSRNOT00000015547
|
Arhgap18
|
Rho GTPase activating protein 18 |
chr20_-_45259928 | 12.75 |
ENSRNOT00000087226
|
Slc16a10
|
solute carrier family 16 member 10 |
chr1_+_85324079 | 12.72 |
ENSRNOT00000093693
|
Samd4b
|
sterile alpha motif domain containing 4B |
chr1_-_80666566 | 12.51 |
ENSRNOT00000082125
ENSRNOT00000025388 |
Nectin2
|
nectin cell adhesion molecule 2 |
chr10_+_89484468 | 12.42 |
ENSRNOT00000035523
|
Tmem106a
|
transmembrane protein 106A |
chr19_+_24456976 | 12.37 |
ENSRNOT00000004900
|
Ucp1
|
uncoupling protein 1 |
chr8_+_96564877 | 12.28 |
ENSRNOT00000017879
|
Mthfs
|
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) |
chr6_+_144291974 | 12.15 |
ENSRNOT00000035255
|
Ncapg2
|
non-SMC condensin II complex, subunit G2 |
chr1_+_214434626 | 12.10 |
ENSRNOT00000025319
|
Pnpla2
|
patatin-like phospholipase domain containing 2 |
chr11_-_30977483 | 12.01 |
ENSRNOT00000002851
|
Urb1
|
URB1 ribosome biogenesis 1 homolog (S. cerevisiae) |
chr8_-_22929294 | 11.97 |
ENSRNOT00000015609
|
Rab3d
|
RAB3D, member RAS oncogene family |
chr2_+_190073815 | 11.94 |
ENSRNOT00000015473
|
S100a8
|
S100 calcium binding protein A8 |
chr7_+_142912316 | 11.86 |
ENSRNOT00000010171
|
Nr4a1
|
nuclear receptor subfamily 4, group A, member 1 |
chr2_-_207300854 | 11.82 |
ENSRNOT00000018061
|
Mov10
|
Mov10 RISC complex RNA helicase |
chr18_-_28454756 | 11.81 |
ENSRNOT00000040091
|
Spata24
|
spermatogenesis associated 24 |
chr5_+_145188323 | 11.80 |
ENSRNOT00000038888
|
Tmem35b
|
transmembrane protein 35B |
chr9_-_9702306 | 11.77 |
ENSRNOT00000082341
|
Trip10
|
thyroid hormone receptor interactor 10 |
chr9_+_20765296 | 11.72 |
ENSRNOT00000016291
|
Cd2ap
|
CD2-associated protein |
chr16_-_20890949 | 11.69 |
ENSRNOT00000081977
|
Homer3
|
homer scaffolding protein 3 |
chr10_-_56962161 | 11.68 |
ENSRNOT00000026038
|
Alox15
|
arachidonate 15-lipoxygenase |
chr2_+_209097927 | 11.66 |
ENSRNOT00000023807
|
Dennd2d
|
DENN domain containing 2D |
chr1_+_213997709 | 11.52 |
ENSRNOT00000025826
|
LOC100911615
|
patatin-like phospholipase domain-containing protein 2-like |
chr3_+_100366168 | 11.45 |
ENSRNOT00000006689
|
Kif18a
|
kinesin family member 18A |
chr12_+_38490230 | 11.35 |
ENSRNOT00000047861
|
Diablo
|
diablo, IAP-binding mitochondrial protein |
chr5_+_172986291 | 11.28 |
ENSRNOT00000022900
|
Nadk
|
NAD kinase |
chr3_+_164274710 | 11.25 |
ENSRNOT00000012939
|
Snai1
|
snail family transcriptional repressor 1 |
chr5_+_139468546 | 11.22 |
ENSRNOT00000013193
|
Slfnl1
|
schlafen-like 1 |
chr1_+_166893734 | 11.20 |
ENSRNOT00000026702
|
Phox2a
|
paired-like homeobox 2a |
chr20_-_49486550 | 11.11 |
ENSRNOT00000048270
ENSRNOT00000076541 |
Prdm1
|
PR/SET domain 1 |
chr8_+_22937916 | 11.06 |
ENSRNOT00000088255
ENSRNOT00000049993 |
Ccdc159
|
coiled-coil domain containing 159 |
chr8_+_118206698 | 11.03 |
ENSRNOT00000082607
ENSRNOT00000064140 |
Smarcc1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
chr15_-_11912806 | 10.99 |
ENSRNOT00000068171
ENSRNOT00000008759 ENSRNOT00000049771 |
Slc4a7
|
solute carrier family 4 member 7 |
chr12_+_51948650 | 10.91 |
ENSRNOT00000056735
|
Ep400
|
E1A binding protein p400 |
chr3_+_150323116 | 10.89 |
ENSRNOT00000023429
ENSRNOT00000080485 |
Raly
|
RALY heterogeneous nuclear ribonucleoprotein |
chr2_-_116161998 | 10.77 |
ENSRNOT00000012560
|
Gpr160
|
G protein-coupled receptor 160 |
chr15_+_33108671 | 10.77 |
ENSRNOT00000015468
|
Lrp10
|
LDL receptor related protein 10 |
chr19_-_52499433 | 10.72 |
ENSRNOT00000021954
|
Cotl1
|
coactosin-like F-actin binding protein 1 |
chr11_+_87204175 | 10.69 |
ENSRNOT00000000306
|
Slc25a1
|
solute carrier family 25 member 1 |
chr12_+_22165486 | 10.69 |
ENSRNOT00000001890
|
Mospd3
|
motile sperm domain containing 3 |
chr8_-_22821223 | 10.69 |
ENSRNOT00000014135
|
Kank2
|
KN motif and ankyrin repeat domains 2 |
chr19_-_9931930 | 10.68 |
ENSRNOT00000085144
|
Ccdc113
|
coiled-coil domain containing 113 |
chr4_-_147893992 | 10.67 |
ENSRNOT00000032158
|
Plxnd1
|
plexin D1 |
chr3_-_160738927 | 10.64 |
ENSRNOT00000043470
|
Slpil2
|
antileukoproteinase-like 2 |
chr10_-_37645802 | 10.60 |
ENSRNOT00000008022
|
Tcf7
|
transcription factor 7 (T-cell specific, HMG-box) |
chr7_+_120206188 | 10.54 |
ENSRNOT00000086853
|
Triobp
|
TRIO and F-actin binding protein |
chr10_-_88442796 | 10.52 |
ENSRNOT00000077579
ENSRNOT00000023447 ENSRNOT00000043172 |
Acly
|
ATP citrate lyase |
chr12_-_11265865 | 10.50 |
ENSRNOT00000001315
|
Arpc1b
|
actin related protein 2/3 complex, subunit 1B |
chr1_+_84280945 | 10.50 |
ENSRNOT00000057190
|
Sertad3
|
SERTA domain containing 3 |
chr12_-_24046814 | 10.43 |
ENSRNOT00000001961
|
Por
|
cytochrome p450 oxidoreductase |
chr10_+_56576428 | 10.42 |
ENSRNOT00000079237
ENSRNOT00000023291 |
Cldn7
|
claudin 7 |
chr1_-_87155118 | 10.37 |
ENSRNOT00000072441
|
AABR07002854.1
|
|
chr1_-_256734719 | 10.37 |
ENSRNOT00000021546
ENSRNOT00000089456 |
Myof
|
myoferlin |
chr19_-_19509087 | 10.34 |
ENSRNOT00000019301
|
Nkd1
|
naked cuticle homolog 1 |
chr20_-_31598118 | 10.24 |
ENSRNOT00000046537
|
Col13a1
|
collagen type XIII alpha 1 chain |
chr7_-_2941122 | 10.17 |
ENSRNOT00000082107
|
Esyt1
|
extended synaptotagmin 1 |
chr14_+_79343499 | 10.12 |
ENSRNOT00000077846
|
Tbc1d14
|
TBC1 domain family, member 14 |
chr8_-_48564722 | 10.05 |
ENSRNOT00000067902
|
Cbl
|
Cbl proto-oncogene |
chr3_-_160730360 | 10.05 |
ENSRNOT00000075864
|
RGD1563818
|
similar to secretory leukocyte protease inhibitor |
chr15_+_83442144 | 10.03 |
ENSRNOT00000039344
|
Bora
|
bora, aurora kinase A activator |
chr16_-_21362955 | 10.02 |
ENSRNOT00000039607
|
Gmip
|
Gem-interacting protein |
chr1_-_65551043 | 10.00 |
ENSRNOT00000029996
|
Trim28
|
tripartite motif-containing 28 |
chr18_-_70184337 | 10.00 |
ENSRNOT00000020637
|
Ska1
|
spindle and kinetochore associated complex subunit 1 |
chr2_-_183031214 | 9.94 |
ENSRNOT00000013260
|
LOC679811
|
similar to RIKEN cDNA D930015E06 |
chr10_-_61744976 | 9.91 |
ENSRNOT00000079926
ENSRNOT00000092314 ENSRNOT00000034298 |
Sgsm2
|
small G protein signaling modulator 2 |
chr16_-_20592449 | 9.86 |
ENSRNOT00000026821
|
Isyna1
|
inositol-3-phosphate synthase 1 |
chr20_-_22004209 | 9.85 |
ENSRNOT00000086250
ENSRNOT00000068778 |
Rtkn2
|
rhotekin 2 |
chr3_+_112531703 | 9.85 |
ENSRNOT00000041727
|
LOC100911204
|
protein CASC5-like |
chr1_+_266053002 | 9.84 |
ENSRNOT00000026235
|
Nfkb2
|
nuclear factor kappa B subunit 2 |
chr7_+_12144162 | 9.80 |
ENSRNOT00000077122
|
Tcf3
|
transcription factor 3 |
chr15_+_3436361 | 9.80 |
ENSRNOT00000016387
|
Ap3m1
|
adaptor-related protein complex 3, mu 1 subunit |
chr7_+_12006710 | 9.79 |
ENSRNOT00000045421
|
Klf16
|
Kruppel-like factor 16 |
chr16_-_19942343 | 9.77 |
ENSRNOT00000087162
ENSRNOT00000091906 |
Bst2
|
bone marrow stromal cell antigen 2 |
chr5_-_62260089 | 9.73 |
ENSRNOT00000064858
ENSRNOT00000011714 |
Tbc1d2
|
TBC1 domain family, member 2 |
chr15_-_34269851 | 9.71 |
ENSRNOT00000026279
|
Psme2
|
proteasome activator subunit 2 |
chr4_+_7661558 | 9.71 |
ENSRNOT00000080229
|
Fam126a
|
family with sequence similarity 126, member A |
chr13_-_83457888 | 9.70 |
ENSRNOT00000076289
ENSRNOT00000004065 |
Sft2d2
|
SFT2 domain containing 2 |
chr3_-_63507926 | 9.66 |
ENSRNOT00000015624
|
Prkra
|
protein activator of interferon induced protein kinase EIF2AK2 |
chr3_-_138116664 | 9.63 |
ENSRNOT00000055602
|
Rrbp1
|
ribosome binding protein 1 |
chr6_-_125723732 | 9.60 |
ENSRNOT00000084815
|
Fbln5
|
fibulin 5 |
chr10_+_61772449 | 9.59 |
ENSRNOT00000004058
|
Smg6
|
SMG6 nonsense mediated mRNA decay factor |
chr3_-_160739137 | 9.59 |
ENSRNOT00000075836
|
Slpil2
|
antileukoproteinase-like 2 |
chr2_+_178389799 | 9.56 |
ENSRNOT00000013356
|
RGD1560010
|
RGD1560010 |
chr5_-_160555083 | 9.45 |
ENSRNOT00000018953
|
Fhad1
|
forkhead associated phosphopeptide binding domain 1 |
chr18_-_63488027 | 9.41 |
ENSRNOT00000023763
|
Ptpn2
|
protein tyrosine phosphatase, non-receptor type 2 |
chr13_+_52976507 | 9.37 |
ENSRNOT00000090599
ENSRNOT00000011324 |
Kif21b
|
kinesin family member 21B |
chr19_+_58746313 | 9.34 |
ENSRNOT00000026986
|
Map3k21
|
mitogen-activated protein kinase kinase kinase 21 |
chr10_+_105500290 | 9.30 |
ENSRNOT00000079080
ENSRNOT00000083593 |
Sphk1
|
sphingosine kinase 1 |
chr14_+_37919233 | 9.29 |
ENSRNOT00000003125
|
Tec
|
tec protein tyrosine kinase |
chr20_-_4896970 | 9.20 |
ENSRNOT00000061114
ENSRNOT00000060980 |
RT1-CE7
RT1-CE5
|
RT1 class I, locus CE7 RT1 class I, locus CE5 |
chr1_-_163129641 | 9.20 |
ENSRNOT00000083055
|
Capn5
|
calpain 5 |
chr8_+_117737387 | 9.16 |
ENSRNOT00000090164
ENSRNOT00000091573 |
Pfkfb4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
chr14_-_7863664 | 9.12 |
ENSRNOT00000061162
|
Ptpn13
|
protein tyrosine phosphatase, non-receptor type 13 |
chr4_-_123510217 | 9.12 |
ENSRNOT00000080734
|
Slc41a3
|
solute carrier family 41, member 3 |
chr7_+_114724610 | 9.08 |
ENSRNOT00000014541
|
Dennd3
|
DENN domain containing 3 |
chr9_+_14551758 | 9.07 |
ENSRNOT00000017157
|
Nfya
|
nuclear transcription factor Y subunit alpha |
chr7_-_14189688 | 9.07 |
ENSRNOT00000037456
|
Notch3
|
notch 3 |
chr8_+_116311078 | 9.05 |
ENSRNOT00000037363
|
Rassf1
|
Ras association domain family member 1 |
chr5_-_136002900 | 9.05 |
ENSRNOT00000025197
|
Plk3
|
polo-like kinase 3 |
chr3_-_164095878 | 9.01 |
ENSRNOT00000079414
|
B4galt5
|
beta-1,4-galactosyltransferase 5 |
chr20_+_4355175 | 9.01 |
ENSRNOT00000000510
|
Gpsm3
|
G-protein signaling modulator 3 |
chr19_+_49457677 | 8.99 |
ENSRNOT00000084445
|
Cenpn
|
centromere protein N |
chr1_+_220009397 | 8.98 |
ENSRNOT00000084410
|
Rbm4b
|
RNA binding motif protein 4B |
chr6_+_43884678 | 8.97 |
ENSRNOT00000091551
|
Rrm2
|
ribonucleotide reductase regulatory subunit M2 |
chr7_+_144014173 | 8.94 |
ENSRNOT00000019403
|
Sp1
|
Sp1 transcription factor |
chr10_+_94280703 | 8.92 |
ENSRNOT00000088656
|
Map3k3
|
mitogen activated protein kinase kinase kinase 3 |
chr3_-_82368357 | 8.91 |
ENSRNOT00000000052
|
Cd82
|
Cd82 molecule |
chr10_-_65507581 | 8.88 |
ENSRNOT00000016759
|
Supt6h
|
SPT6 homolog, histone chaperone |
chr5_-_143120165 | 8.87 |
ENSRNOT00000012314
|
Zc3h12a
|
zinc finger CCCH type containing 12A |
chr1_-_80689171 | 8.83 |
ENSRNOT00000045574
|
Bcam
|
basal cell adhesion molecule (Lutheran blood group) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.8 | 35.5 | GO:0042196 | response to salicylic acid(GO:0009751) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
9.1 | 27.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
8.6 | 25.8 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
7.7 | 23.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
7.0 | 21.1 | GO:0031439 | positive regulation of mRNA cleavage(GO:0031439) positive regulation of endoribonuclease activity(GO:1902380) positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904722) |
6.8 | 27.1 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
6.6 | 33.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
6.6 | 26.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
6.1 | 36.5 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
6.0 | 6.0 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
5.7 | 34.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
5.6 | 28.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
5.6 | 27.9 | GO:0010958 | regulation of amino acid import(GO:0010958) glycine import(GO:0036233) |
5.5 | 16.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
5.3 | 26.7 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
5.1 | 20.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
4.8 | 19.2 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
4.8 | 14.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
4.7 | 14.2 | GO:1902211 | regulation of prolactin signaling pathway(GO:1902211) |
4.6 | 69.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
4.5 | 13.5 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
4.5 | 17.9 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
4.3 | 8.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
4.2 | 16.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
4.2 | 12.7 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
4.2 | 46.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
4.2 | 12.5 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
3.8 | 11.4 | GO:0003192 | mitral valve formation(GO:0003192) |
3.7 | 11.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
3.7 | 11.2 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
3.6 | 39.9 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
3.6 | 10.8 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
3.5 | 7.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
3.5 | 10.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
3.5 | 17.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
3.5 | 10.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
3.4 | 24.0 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
3.3 | 10.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
3.3 | 9.9 | GO:0098749 | cerebellar neuron development(GO:0098749) |
3.3 | 6.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
3.3 | 9.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.3 | 16.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
3.3 | 9.8 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
3.2 | 9.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
3.2 | 12.7 | GO:0071640 | regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
3.2 | 9.5 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
3.1 | 9.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
3.1 | 6.3 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
3.1 | 24.9 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
3.0 | 18.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
3.0 | 24.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
3.0 | 8.9 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
2.9 | 11.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.9 | 49.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
2.9 | 5.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
2.9 | 20.1 | GO:0007144 | female meiosis I(GO:0007144) |
2.9 | 2.9 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.8 | 11.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.8 | 8.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
2.8 | 8.4 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
2.8 | 2.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.8 | 8.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
2.8 | 8.4 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
2.8 | 8.3 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
2.8 | 11.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
2.8 | 25.0 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
2.7 | 13.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
2.7 | 10.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
2.7 | 10.7 | GO:0015746 | citrate transport(GO:0015746) |
2.7 | 8.0 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
2.7 | 10.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
2.6 | 10.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.6 | 39.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
2.6 | 15.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
2.6 | 10.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
2.6 | 15.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
2.5 | 17.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
2.5 | 10.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
2.5 | 15.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.5 | 19.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
2.4 | 12.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
2.4 | 4.9 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
2.4 | 7.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
2.4 | 2.4 | GO:0003383 | apical constriction(GO:0003383) |
2.4 | 11.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
2.4 | 11.9 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
2.4 | 11.8 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.3 | 7.0 | GO:0061198 | fungiform papilla formation(GO:0061198) |
2.3 | 2.3 | GO:1904585 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) |
2.3 | 30.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
2.3 | 16.1 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) |
2.3 | 6.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
2.3 | 11.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
2.3 | 6.8 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
2.3 | 25.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
2.3 | 11.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.3 | 6.8 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
2.2 | 15.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
2.2 | 6.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) endocardial cushion cell differentiation(GO:0061443) |
2.2 | 6.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) protein localization to vacuolar membrane(GO:1903778) |
2.2 | 6.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
2.2 | 12.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
2.1 | 2.1 | GO:1901656 | glycoside transport(GO:1901656) |
2.1 | 8.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
2.1 | 4.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
2.1 | 8.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.1 | 14.4 | GO:0006868 | glutamine transport(GO:0006868) |
2.0 | 10.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
2.0 | 2.0 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
2.0 | 6.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
2.0 | 6.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
2.0 | 6.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
2.0 | 7.9 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
2.0 | 7.9 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
2.0 | 11.9 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
2.0 | 2.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.9 | 7.8 | GO:0035938 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
1.9 | 5.8 | GO:0072237 | distal tubule morphogenesis(GO:0072156) metanephric proximal tubule development(GO:0072237) |
1.9 | 7.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.9 | 3.8 | GO:0060982 | cardiac right ventricle formation(GO:0003219) coronary artery morphogenesis(GO:0060982) |
1.9 | 5.7 | GO:0002432 | granuloma formation(GO:0002432) |
1.9 | 22.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
1.9 | 13.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.9 | 5.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
1.9 | 5.6 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.9 | 5.6 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
1.9 | 5.6 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
1.8 | 12.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.8 | 9.2 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
1.8 | 7.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.8 | 16.5 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.8 | 5.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
1.8 | 18.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.8 | 25.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.8 | 1.8 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.8 | 10.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.8 | 7.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.8 | 7.0 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.7 | 8.7 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.7 | 5.2 | GO:0021997 | neural plate axis specification(GO:0021997) |
1.7 | 5.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.7 | 1.7 | GO:1901258 | positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
1.7 | 10.0 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.7 | 6.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.7 | 5.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.6 | 8.2 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
1.6 | 6.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.6 | 1.6 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.6 | 4.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.6 | 9.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.6 | 6.3 | GO:1901423 | response to benzene(GO:1901423) |
1.6 | 11.0 | GO:0071284 | cellular response to lead ion(GO:0071284) |
1.6 | 6.3 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.5 | 4.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.5 | 4.6 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
1.5 | 6.2 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
1.5 | 21.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
1.5 | 18.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
1.5 | 13.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.5 | 4.6 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
1.5 | 3.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.5 | 6.1 | GO:1904587 | response to glycoprotein(GO:1904587) |
1.5 | 4.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.5 | 38.7 | GO:0044253 | positive regulation of multicellular organismal metabolic process(GO:0044253) |
1.5 | 5.9 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.5 | 2.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.4 | 7.2 | GO:0071681 | cellular response to indole-3-methanol(GO:0071681) |
1.4 | 18.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.4 | 4.3 | GO:1904373 | response to kainic acid(GO:1904373) |
1.4 | 4.2 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
1.4 | 4.2 | GO:0032242 | regulation of nucleoside transport(GO:0032242) positive regulation of necroptotic process(GO:0060545) |
1.4 | 9.7 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
1.4 | 5.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.4 | 6.9 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
1.4 | 1.4 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
1.4 | 10.9 | GO:0001842 | neural fold formation(GO:0001842) |
1.4 | 2.7 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
1.3 | 6.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
1.3 | 2.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
1.3 | 2.7 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
1.3 | 26.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
1.3 | 13.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.3 | 2.6 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.3 | 2.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.3 | 6.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.3 | 12.7 | GO:0002467 | germinal center formation(GO:0002467) |
1.3 | 22.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.3 | 8.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.2 | 6.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.2 | 3.7 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
1.2 | 7.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
1.2 | 3.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.2 | 2.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.2 | 47.2 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
1.2 | 3.6 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
1.2 | 3.6 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
1.2 | 4.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.2 | 2.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
1.2 | 3.6 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.2 | 4.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.2 | 11.8 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
1.2 | 7.0 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
1.2 | 7.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.2 | 8.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.2 | 5.8 | GO:0072553 | terminal button organization(GO:0072553) |
1.2 | 3.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 4.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.1 | 4.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.1 | 3.4 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) |
1.1 | 3.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.1 | 8.0 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
1.1 | 13.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.1 | 4.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.1 | 5.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.1 | 5.7 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.1 | 7.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.1 | 6.8 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.1 | 1.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.1 | 2.2 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.1 | 2.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.1 | 3.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.1 | 3.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.1 | 12.1 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
1.1 | 13.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.1 | 2.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.1 | 7.5 | GO:0070836 | caveola assembly(GO:0070836) |
1.1 | 14.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.1 | 3.2 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
1.1 | 12.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.1 | 3.2 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
1.1 | 1.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.0 | 8.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.0 | 2.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.0 | 4.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.0 | 2.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.0 | 11.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
1.0 | 11.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
1.0 | 6.0 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
1.0 | 3.0 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
1.0 | 3.0 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
1.0 | 66.3 | GO:0046847 | filopodium assembly(GO:0046847) |
1.0 | 34.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
1.0 | 2.0 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
1.0 | 6.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
1.0 | 20.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
1.0 | 2.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.0 | 3.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.0 | 1.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.0 | 10.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.0 | 36.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
1.0 | 5.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.9 | 10.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.9 | 1.9 | GO:0032762 | mast cell cytokine production(GO:0032762) positive regulation of relaxation of muscle(GO:1901079) |
0.9 | 7.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.9 | 3.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.9 | 2.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.9 | 0.9 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.9 | 3.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.9 | 2.7 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.9 | 2.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.9 | 3.6 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.9 | 3.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.9 | 2.7 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.9 | 9.9 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.9 | 9.7 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.9 | 5.3 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.9 | 5.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.9 | 1.7 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.9 | 3.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.9 | 4.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.8 | 4.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.8 | 10.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.8 | 1.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.8 | 1.7 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.8 | 2.5 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.8 | 10.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.8 | 10.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.8 | 3.3 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.8 | 3.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.8 | 1.6 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.8 | 18.4 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.8 | 4.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.8 | 3.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.8 | 4.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.8 | 4.8 | GO:0015074 | DNA integration(GO:0015074) |
0.8 | 3.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.8 | 3.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.8 | 8.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 3.9 | GO:0030952 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.8 | 2.3 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.8 | 5.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.8 | 11.6 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.8 | 2.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.8 | 3.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.8 | 4.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.8 | 3.8 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.8 | 2.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.7 | 7.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.7 | 2.2 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.7 | 9.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.7 | 0.7 | GO:1902861 | copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.7 | 4.4 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.7 | 2.2 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.7 | 12.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.7 | 6.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.7 | 2.9 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.7 | 9.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.7 | 0.7 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.7 | 3.6 | GO:1904401 | cellular response to Thyroid stimulating hormone(GO:1904401) |
0.7 | 14.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) |
0.7 | 1.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.7 | 1.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.7 | 7.9 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.7 | 3.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.7 | 9.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.7 | 2.8 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.7 | 18.8 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.7 | 5.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.7 | 2.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.7 | 3.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.7 | 6.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.7 | 6.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.7 | 1.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.7 | 1.4 | GO:0060003 | copper ion export(GO:0060003) |
0.7 | 2.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 1.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.7 | 2.7 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.7 | 4.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.7 | 3.4 | GO:0032506 | cytokinetic process(GO:0032506) |
0.7 | 2.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.7 | 5.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.7 | 9.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 10.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.7 | 2.0 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.7 | 2.7 | GO:0045869 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.7 | 2.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.7 | 10.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.7 | 2.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.7 | 2.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.7 | 2.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.7 | 2.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.6 | 1.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.6 | 7.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.6 | 1.3 | GO:0045575 | basophil activation(GO:0045575) |
0.6 | 1.9 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.6 | 27.2 | GO:0043297 | apical junction assembly(GO:0043297) |
0.6 | 6.9 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.6 | 3.1 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.6 | 5.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.6 | 1.9 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.6 | 5.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 3.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.6 | 34.1 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.6 | 1.9 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.6 | 0.6 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.6 | 1.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 3.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.6 | 1.8 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.6 | 3.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.6 | 10.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.6 | 12.1 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.6 | 1.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 1.8 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.6 | 16.8 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.6 | 1.8 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.6 | 2.4 | GO:0018158 | protein oxidation(GO:0018158) |
0.6 | 4.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.6 | 1.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.6 | 2.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.6 | 1.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 3.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 0.6 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.6 | 1.7 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.6 | 1.7 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) positive regulation of somatostatin secretion(GO:0090274) |
0.6 | 1.2 | GO:0030421 | defecation(GO:0030421) |
0.6 | 5.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.6 | 5.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.6 | 10.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.6 | 10.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.6 | 2.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.6 | 3.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 1.7 | GO:0035696 | monocyte extravasation(GO:0035696) |
0.6 | 6.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.6 | 2.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.6 | 1.7 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.5 | 4.9 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 1.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.5 | 1.6 | GO:0032218 | riboflavin transport(GO:0032218) |
0.5 | 2.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.5 | 3.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.5 | 2.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 1.6 | GO:1901227 | negative regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901227) |
0.5 | 8.7 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.5 | 3.2 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.5 | 13.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 3.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 15.0 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.5 | 2.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 1.1 | GO:0070672 | negative regulation of icosanoid secretion(GO:0032304) response to interleukin-15(GO:0070672) |
0.5 | 8.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.5 | 2.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.5 | 8.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.5 | 9.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 4.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.5 | 2.1 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.5 | 1.5 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.5 | 3.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.5 | 8.2 | GO:0007143 | female meiotic division(GO:0007143) |
0.5 | 11.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.5 | 2.0 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.5 | 4.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.5 | 5.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.5 | 5.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.5 | 6.0 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 5.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 6.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.5 | 1.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 3.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.5 | 1.5 | GO:0043485 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.5 | 2.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 2.9 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.5 | 9.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.5 | 11.6 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.5 | 1.4 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.5 | 3.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.5 | 3.7 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.5 | 2.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 1.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 11.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.5 | 1.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.5 | 2.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 2.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 0.9 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.5 | 2.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 3.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 2.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.5 | 2.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 2.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 0.4 | GO:0070370 | cellular heat acclimation(GO:0070370) |
0.4 | 11.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.4 | 1.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 7.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 3.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.4 | 1.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.4 | 3.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.4 | 1.3 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.4 | 1.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.4 | 2.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.4 | 1.3 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.4 | 3.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 2.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.4 | 3.9 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.4 | 1.7 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.4 | 5.5 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.4 | 3.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 5.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.4 | 5.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.4 | 9.3 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.4 | 9.3 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.4 | 8.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.4 | 4.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.4 | 18.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.4 | 4.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.4 | 0.8 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.4 | 15.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 1.6 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.4 | 7.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 1.6 | GO:0072268 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
0.4 | 7.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.4 | 1.6 | GO:0071000 | response to magnetism(GO:0071000) |
0.4 | 2.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.4 | 2.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.4 | 3.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.4 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 4.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 0.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 6.7 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.4 | 4.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.4 | 0.8 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.4 | 5.4 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.4 | 5.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 2.7 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 7.6 | GO:0007099 | centriole replication(GO:0007099) |
0.4 | 4.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 3.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 11.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 4.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.4 | 0.4 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.4 | 2.6 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.4 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 1.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.4 | 2.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 1.1 | GO:0043311 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) regulation of eosinophil activation(GO:1902566) positive regulation of eosinophil activation(GO:1902568) |
0.4 | 0.7 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 | 5.7 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.4 | 1.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 2.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 4.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 0.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.3 | 2.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 2.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.3 | 8.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.3 | 2.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 1.7 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.3 | 0.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 2.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 1.0 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.3 | 9.2 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.3 | 1.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.7 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.3 | 1.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 2.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 2.0 | GO:0032264 | IMP salvage(GO:0032264) |
0.3 | 3.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 2.0 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.3 | 2.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 1.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 4.5 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 9.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 3.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 0.6 | GO:0019042 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.3 | 1.0 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.3 | 8.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.3 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 3.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 3.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.3 | 2.4 | GO:0009651 | response to salt stress(GO:0009651) |
0.3 | 4.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.3 | 2.4 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.3 | 2.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 6.0 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.3 | 0.9 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 3.5 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 2.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 2.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 1.1 | GO:1904117 | cellular response to vasopressin(GO:1904117) |
0.3 | 4.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 2.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 3.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 2.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 1.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.3 | 0.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.3 | 2.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.3 | GO:0043132 | NAD transport(GO:0043132) |
0.3 | 3.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.3 | 1.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.3 | 5.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 0.3 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.3 | 2.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.3 | 2.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 0.8 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 1.8 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 1.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 1.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 1.0 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
0.3 | 1.0 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.3 | 1.5 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 2.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.3 | 1.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 2.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 7.5 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.2 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.7 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 3.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 1.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 1.0 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 5.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 1.0 | GO:0039531 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) |
0.2 | 6.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 1.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 4.0 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 6.2 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.2 | 3.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.2 | 1.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 1.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.2 | 0.5 | GO:0030242 | pexophagy(GO:0030242) CVT pathway(GO:0032258) |
0.2 | 3.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 2.2 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.2 | 0.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 7.6 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.2 | 3.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 3.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.7 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.2 | 0.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 3.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.9 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.4 | GO:1903912 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 4.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.2 | 1.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 1.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.2 | 0.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 1.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 2.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 1.6 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 0.6 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.2 | 1.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 1.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.6 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.2 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 2.4 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.2 | 3.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 4.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 1.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 7.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.9 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.2 | 1.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 3.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 1.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 6.2 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.2 | 2.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 1.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 1.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 0.7 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 2.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 6.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 16.9 | GO:0006302 | double-strand break repair(GO:0006302) |
0.2 | 2.0 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 2.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 1.8 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.2 | 0.5 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 1.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.5 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.2 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.5 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.2 | 1.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.2 | 4.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 1.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 2.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 3.9 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 1.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 1.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 8.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 3.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 1.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.7 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 0.8 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 1.0 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 1.8 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 2.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 1.5 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 2.0 | GO:0060038 | cardiac muscle cell proliferation(GO:0060038) |
0.1 | 1.6 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 1.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.3 | GO:0045064 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) T-helper 2 cell differentiation(GO:0045064) negative regulation of T-helper cell differentiation(GO:0045623) regulation of T-helper 2 cell differentiation(GO:0045628) |
0.1 | 0.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 3.0 | GO:1903557 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.1 | 0.3 | GO:0060969 | negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing(GO:0060969) |
0.1 | 0.5 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 2.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 1.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 2.8 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 10.2 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 2.7 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 1.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 1.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 2.7 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.1 | 0.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 1.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 3.4 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 10.1 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 2.8 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 2.3 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 4.7 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 18.6 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.1 | 0.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 1.2 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
0.1 | 1.6 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 20.5 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.1 | 0.6 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.1 | GO:0034486 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
0.1 | 3.9 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 1.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 2.8 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.9 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 2.1 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 1.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 6.1 | GO:0042113 | B cell activation(GO:0042113) |
0.1 | 2.1 | GO:0001843 | neural tube closure(GO:0001843) primary neural tube formation(GO:0014020) tube closure(GO:0060606) |
0.1 | 0.7 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.5 | GO:0046638 | positive regulation of alpha-beta T cell differentiation(GO:0046638) |
0.1 | 1.6 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 1.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 1.1 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.8 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 0.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.2 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.7 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 1.6 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.8 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.4 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.6 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 1.1 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 10.7 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 2.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.5 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.2 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.8 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.0 | GO:0002369 | T cell cytokine production(GO:0002369) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.4 | 41.7 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
6.1 | 6.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
6.1 | 48.5 | GO:0000796 | condensin complex(GO:0000796) |
5.8 | 23.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
5.7 | 17.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
5.2 | 46.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
4.5 | 36.4 | GO:0097443 | sorting endosome(GO:0097443) |
4.5 | 13.5 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
4.3 | 34.3 | GO:0044194 | cytolytic granule(GO:0044194) |
3.8 | 11.3 | GO:0000811 | GINS complex(GO:0000811) |
3.6 | 18.1 | GO:0071953 | elastic fiber(GO:0071953) |
3.2 | 9.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
3.2 | 12.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
2.9 | 8.7 | GO:0044317 | rod spherule(GO:0044317) |
2.8 | 53.2 | GO:0032433 | filopodium tip(GO:0032433) |
2.8 | 8.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
2.7 | 8.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.7 | 8.1 | GO:1990423 | RZZ complex(GO:1990423) |
2.7 | 10.8 | GO:0070876 | SOSS complex(GO:0070876) |
2.4 | 4.8 | GO:1990005 | granular vesicle(GO:1990005) |
2.2 | 9.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.2 | 8.7 | GO:0097427 | microtubule bundle(GO:0097427) |
2.1 | 10.3 | GO:0043293 | apoptosome(GO:0043293) |
2.0 | 20.4 | GO:0070652 | HAUS complex(GO:0070652) |
1.9 | 7.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
1.9 | 7.4 | GO:0032021 | NELF complex(GO:0032021) |
1.8 | 27.5 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
1.8 | 7.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.8 | 5.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.8 | 30.1 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
1.7 | 8.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.7 | 8.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.7 | 5.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.7 | 11.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.7 | 11.8 | GO:0071203 | WASH complex(GO:0071203) |
1.7 | 16.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.6 | 11.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.6 | 3.3 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.6 | 8.1 | GO:0070695 | FHF complex(GO:0070695) |
1.6 | 8.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.6 | 7.9 | GO:0098536 | deuterosome(GO:0098536) |
1.6 | 12.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.5 | 20.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.5 | 4.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.5 | 4.5 | GO:0061574 | ASAP complex(GO:0061574) |
1.5 | 16.4 | GO:0005915 | zonula adherens(GO:0005915) |
1.4 | 31.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.4 | 14.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.3 | 38.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.3 | 3.8 | GO:0035101 | FACT complex(GO:0035101) |
1.3 | 16.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.3 | 8.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.3 | 3.8 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
1.2 | 10.9 | GO:0000812 | Swr1 complex(GO:0000812) |
1.2 | 4.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.2 | 8.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.1 | 8.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.1 | 14.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.1 | 10.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.1 | 13.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.1 | 10.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.1 | 3.3 | GO:0005745 | m-AAA complex(GO:0005745) |
1.1 | 2.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.1 | 3.3 | GO:0055087 | Ski complex(GO:0055087) |
1.1 | 3.2 | GO:0043511 | inhibin complex(GO:0043511) |
1.1 | 6.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.1 | 3.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
1.1 | 8.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.0 | 3.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.0 | 13.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.0 | 3.0 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
1.0 | 2.0 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
1.0 | 73.1 | GO:0005811 | lipid particle(GO:0005811) |
0.9 | 4.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.9 | 6.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.9 | 27.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.9 | 11.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.9 | 7.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.9 | 4.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.9 | 7.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.9 | 21.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.9 | 7.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.9 | 8.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 11.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 3.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.8 | 10.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.8 | 5.0 | GO:0034464 | BBSome(GO:0034464) |
0.8 | 4.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.8 | 31.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.8 | 4.6 | GO:0001740 | Barr body(GO:0001740) |
0.8 | 72.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.8 | 16.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.8 | 1.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 2.3 | GO:0071942 | XPC complex(GO:0071942) |
0.8 | 3.8 | GO:0034455 | t-UTP complex(GO:0034455) |
0.7 | 2.2 | GO:1990923 | PET complex(GO:1990923) |
0.7 | 22.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.7 | 5.1 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.7 | 2.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 34.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.7 | 3.5 | GO:0042825 | TAP complex(GO:0042825) |
0.7 | 19.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.7 | 3.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.7 | 2.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.7 | 9.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.7 | 5.4 | GO:0097433 | dense body(GO:0097433) |
0.7 | 2.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.7 | 3.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 3.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.6 | 4.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.6 | 1.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.6 | 7.0 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 7.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.6 | 8.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.6 | 1.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 6.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.6 | 2.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.6 | 4.9 | GO:0042555 | MCM complex(GO:0042555) |
0.6 | 7.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.6 | 3.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.6 | 16.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.6 | 12.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.6 | 1.8 | GO:0097227 | sperm annulus(GO:0097227) |
0.6 | 15.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.6 | 1.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.6 | 64.3 | GO:0030496 | midbody(GO:0030496) |
0.6 | 5.8 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 9.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 4.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 4.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.6 | 4.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.6 | 21.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.6 | 1.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 1.6 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 3.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.5 | 4.2 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.5 | 3.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 6.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.5 | 3.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.5 | 39.8 | GO:0032432 | actin filament bundle(GO:0032432) |
0.5 | 3.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 5.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.5 | 3.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 5.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 2.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 6.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 2.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 3.8 | GO:0051286 | cell tip(GO:0051286) |
0.5 | 4.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 7.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.5 | 2.7 | GO:0042641 | actomyosin(GO:0042641) |
0.5 | 1.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 2.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.5 | 8.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.4 | 3.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 1.8 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
0.4 | 1.3 | GO:1990879 | CST complex(GO:1990879) |
0.4 | 13.2 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.4 | 5.2 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 1.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 49.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 96.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.4 | 3.9 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 29.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 14.0 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 3.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.4 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 10.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 7.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 2.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 3.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 1.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 5.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 102.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 2.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 4.8 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 0.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 45.8 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 94.4 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 9.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 1.9 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 3.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 0.9 | GO:0034657 | GID complex(GO:0034657) |
0.3 | 25.3 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 13.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.3 | 3.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 3.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 8.7 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 1.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 2.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.3 | 1.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.0 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 1.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 1.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 1.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 6.4 | GO:0005844 | polysome(GO:0005844) |
0.2 | 4.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 2.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 3.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 4.3 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 1.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 1.3 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 19.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 8.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 5.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 3.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.6 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.2 | 3.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 2.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 1.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 8.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 12.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 4.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 12.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 11.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 8.5 | GO:0005814 | centriole(GO:0005814) |
0.2 | 6.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 1.3 | GO:0001741 | XY body(GO:0001741) |
0.2 | 7.4 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 1.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 7.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 10.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 1.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.5 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 1.0 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 3.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 2.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.5 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.8 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 9.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 5.1 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 1.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 6.9 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 8.3 | GO:0005901 | caveola(GO:0005901) |
0.1 | 2.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 5.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 4.2 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 25.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 5.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 5.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 3.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 1.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.0 | GO:0070161 | anchoring junction(GO:0070161) |
0.1 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 26.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 2.3 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 4.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 26.9 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.6 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 34.6 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.5 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.2 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.0 | 2.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 1.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.6 | 49.9 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
9.3 | 55.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
8.6 | 25.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
7.0 | 21.1 | GO:0031249 | denatured protein binding(GO:0031249) |
6.3 | 31.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
6.1 | 18.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
6.0 | 6.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
5.4 | 16.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
4.9 | 14.8 | GO:0030977 | taurine binding(GO:0030977) |
4.4 | 17.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
4.2 | 88.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
4.1 | 16.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
4.1 | 12.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
4.1 | 16.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
4.0 | 15.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.9 | 30.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) vascular endothelial growth factor binding(GO:0038085) |
3.6 | 10.8 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
3.5 | 10.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
3.5 | 24.2 | GO:0003896 | DNA primase activity(GO:0003896) |
3.4 | 20.3 | GO:0017040 | ceramidase activity(GO:0017040) |
3.3 | 13.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
3.3 | 19.8 | GO:0046979 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
3.3 | 13.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
3.2 | 9.7 | GO:0016403 | dimethylargininase activity(GO:0016403) |
3.1 | 9.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
3.1 | 9.3 | GO:0008481 | sphinganine kinase activity(GO:0008481) |
3.1 | 12.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.9 | 20.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
2.9 | 5.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
2.7 | 8.2 | GO:0000991 | transcription factor activity, core RNA polymerase II binding(GO:0000991) |
2.7 | 10.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) |
2.7 | 8.0 | GO:0047522 | 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
2.5 | 7.5 | GO:0048030 | disaccharide binding(GO:0048030) |
2.4 | 7.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
2.3 | 9.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.3 | 7.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
2.3 | 27.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
2.3 | 16.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
2.2 | 11.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
2.2 | 8.9 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
2.2 | 6.6 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
2.2 | 8.7 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
2.1 | 29.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
2.1 | 14.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
2.1 | 6.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
2.1 | 2.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.0 | 26.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
2.0 | 11.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.9 | 5.8 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
1.9 | 5.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
1.9 | 5.6 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
1.9 | 11.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.8 | 1.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.8 | 11.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.8 | 10.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.8 | 17.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.8 | 8.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.7 | 15.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.7 | 56.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.7 | 8.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.7 | 6.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.7 | 5.0 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) phosphopantetheine binding(GO:0031177) |
1.7 | 5.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.6 | 37.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.6 | 4.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.6 | 7.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
1.6 | 7.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.6 | 7.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.6 | 3.1 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
1.5 | 4.5 | GO:0004335 | galactokinase activity(GO:0004335) |
1.5 | 9.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.4 | 8.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.4 | 5.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
1.4 | 10.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) |
1.4 | 14.9 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.4 | 2.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
1.3 | 10.7 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 6.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.3 | 5.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 5.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.3 | 13.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.3 | 18.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.3 | 5.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.3 | 5.2 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
1.3 | 11.5 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
1.3 | 6.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.3 | 6.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.3 | 34.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.3 | 7.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.2 | 19.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.2 | 5.0 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
1.2 | 20.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.2 | 5.9 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.2 | 14.0 | GO:1990405 | protein antigen binding(GO:1990405) |
1.1 | 3.4 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
1.1 | 11.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.1 | 3.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.1 | 4.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.1 | 2.2 | GO:0035877 | death effector domain binding(GO:0035877) |
1.1 | 12.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.1 | 3.3 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.1 | 4.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.1 | 3.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.1 | 3.3 | GO:0005135 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
1.1 | 2.2 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
1.1 | 52.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.1 | 5.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.1 | 9.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.1 | 3.2 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
1.0 | 11.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.0 | 6.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.0 | 6.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.0 | 3.1 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
1.0 | 6.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.0 | 1.0 | GO:0052833 | inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.0 | 4.0 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.0 | 7.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.0 | 1.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.0 | 3.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.9 | 2.8 | GO:0034041 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) glycoprotein transporter activity(GO:0034437) |
0.9 | 2.7 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.9 | 4.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.9 | 19.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.9 | 2.7 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.9 | 3.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.9 | 2.7 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.9 | 2.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.9 | 1.8 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.9 | 5.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.9 | 3.5 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.9 | 4.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.9 | 3.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 2.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.9 | 2.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.8 | 4.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.8 | 4.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.8 | 1.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 10.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.8 | 3.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.8 | 3.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.8 | 3.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.8 | 20.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.8 | 17.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 2.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 3.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.8 | 4.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 4.7 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.8 | 10.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.8 | 2.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.8 | 2.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.8 | 4.6 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.8 | 3.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.8 | 3.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 22.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.8 | 3.8 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.7 | 16.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.7 | 0.7 | GO:0017050 | D-erythro-sphingosine kinase activity(GO:0017050) |
0.7 | 3.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.7 | 6.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 3.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.7 | 3.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 2.9 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.7 | 2.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.7 | 16.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 7.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.7 | 4.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.7 | 2.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.7 | 6.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.7 | 7.6 | GO:0070513 | death domain binding(GO:0070513) |
0.7 | 4.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 1.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.7 | 11.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.7 | 3.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 2.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.7 | 8.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.7 | 8.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 40.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.7 | 6.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.7 | 2.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.7 | 7.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 2.0 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 2.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.6 | 25.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.6 | 1.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.6 | 3.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.6 | 2.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 3.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 2.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.6 | 1.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 4.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 2.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 15.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.6 | 1.7 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.6 | 25.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 2.3 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.6 | 15.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.6 | 4.5 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 7.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 2.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.5 | 1.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.5 | 2.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.5 | 1.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.5 | 30.7 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 3.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 3.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 2.7 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) MutLalpha complex binding(GO:0032405) |
0.5 | 2.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.5 | 11.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 3.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.5 | 2.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.5 | 2.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 17.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 11.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 11.6 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 5.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 10.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.5 | 11.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.5 | 3.4 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.5 | 2.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 1.4 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.5 | 75.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.5 | 1.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.5 | 11.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 3.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 7.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.5 | 11.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.5 | 17.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.5 | 10.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.5 | 37.2 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.5 | 2.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 3.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 2.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 1.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 1.8 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.4 | 8.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 2.7 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 36.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 1.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 3.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 2.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 5.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.4 | 6.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 2.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 0.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 5.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 75.3 | GO:0061135 | endopeptidase inhibitor activity(GO:0004866) endopeptidase regulator activity(GO:0061135) |
0.4 | 1.3 | GO:0035651 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) AP-3 adaptor complex binding(GO:0035651) |
0.4 | 3.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 9.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 7.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 8.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 5.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 2.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 15.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 1.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 2.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 3.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.4 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 1.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 1.2 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
0.4 | 6.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 3.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 30.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 2.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 7.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 3.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 11.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 6.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 2.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 65.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.4 | 2.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 1.1 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
0.4 | 1.1 | GO:0052724 | inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 3.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 7.3 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 5.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.4 | 2.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.4 | 11.3 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.4 | 6.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 2.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.4 | 1.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 10.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 14.6 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 7.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 3.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 0.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 1.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 1.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 3.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 2.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 7.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 6.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 0.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.3 | 15.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.3 | 1.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 2.0 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.3 | 6.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 5.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 11.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 2.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 2.2 | GO:0034595 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) inositol-polyphosphate 5-phosphatase activity(GO:0004445) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.3 | 2.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 1.4 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.3 | 33.2 | GO:0003774 | motor activity(GO:0003774) |
0.3 | 3.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 3.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 3.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 4.5 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 3.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 1.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 7.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 3.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 2.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 2.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 4.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 1.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 1.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 1.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 51.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 2.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 5.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 63.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 1.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 1.1 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 7.8 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.2 | 5.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 1.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 2.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.3 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 6.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 3.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 3.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 1.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.6 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 1.9 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 3.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.9 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 1.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 2.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 2.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 2.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 16.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.5 | GO:0004159 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) dihydrouracil dehydrogenase (NAD+) activity(GO:0004159) dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113) |
0.2 | 0.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 2.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 1.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.5 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.2 | 2.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 2.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 29.3 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.2 | 2.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.2 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 9.9 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 6.6 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 2.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 12.5 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 1.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 2.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 6.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 2.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 2.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 3.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.6 | GO:0070401 | NADP+ binding(GO:0070401) |
0.1 | 0.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 6.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 48.7 | GO:0000975 | regulatory region DNA binding(GO:0000975) regulatory region nucleic acid binding(GO:0001067) |
0.1 | 3.9 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.1 | 2.2 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 7.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 2.4 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 3.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 13.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 1.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.4 | GO:0000829 | inositol heptakisphosphate kinase activity(GO:0000829) |
0.1 | 1.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 8.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 6.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 19.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.3 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 2.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.1 | 0.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 10.4 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 7.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 1.8 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 18.2 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 1.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 1.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 4.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 1.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 34.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
2.0 | 77.3 | PID BARD1 PATHWAY | BARD1 signaling events |
1.9 | 9.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.9 | 9.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.5 | 12.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.5 | 12.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.5 | 14.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.3 | 37.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.3 | 47.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.3 | 59.6 | PID AURORA B PATHWAY | Aurora B signaling |
1.3 | 66.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.2 | 48.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.2 | 23.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.2 | 35.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.1 | 33.7 | PID EPO PATHWAY | EPO signaling pathway |
1.1 | 7.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.1 | 20.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.0 | 10.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.0 | 16.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.0 | 33.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.0 | 11.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.0 | 9.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.9 | 3.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.9 | 2.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.9 | 3.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 27.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.9 | 40.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.8 | 12.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.8 | 7.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.8 | 5.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.7 | 39.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.7 | 7.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.7 | 32.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 22.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.7 | 23.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.7 | 19.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 25.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 13.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.7 | 12.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.7 | 28.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.7 | 11.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 13.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 21.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.6 | 26.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.6 | 36.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.6 | 4.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 58.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 20.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 17.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.5 | 29.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 2.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 9.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 20.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 2.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 27.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 14.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 5.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 6.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 10.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 2.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.4 | 6.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 2.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 6.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 5.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 10.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 1.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 3.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 13.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 6.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 7.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 6.5 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 3.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 2.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 2.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 3.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 2.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 6.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 8.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 2.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 3.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 2.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 1.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 5.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 5.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 2.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 2.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 3.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 8.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 28.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 13.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 2.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 14.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 3.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.8 | 33.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
2.5 | 54.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
2.2 | 40.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.2 | 26.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
2.1 | 21.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.0 | 79.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.0 | 37.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.8 | 19.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.8 | 5.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.7 | 20.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.6 | 1.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.6 | 43.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.6 | 31.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.5 | 46.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.5 | 16.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.5 | 22.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.4 | 14.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.2 | 19.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.1 | 3.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.1 | 6.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.0 | 3.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.0 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.0 | 10.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.9 | 34.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.9 | 11.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.9 | 20.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.9 | 15.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.9 | 14.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.8 | 95.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.8 | 38.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 9.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.8 | 10.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 3.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.8 | 6.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.8 | 5.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 12.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.7 | 7.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.7 | 21.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.7 | 7.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.6 | 2.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.6 | 28.9 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.6 | 17.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.6 | 10.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.6 | 18.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.6 | 17.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 8.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 3.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 12.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 4.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.6 | 7.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.6 | 7.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.6 | 34.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 14.0 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.6 | 37.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 9.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.6 | 5.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.5 | 22.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.5 | 22.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 25.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 6.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 5.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 10.8 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.5 | 28.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 10.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 10.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.4 | 48.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 1.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 8.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.4 | 23.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 5.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 8.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 2.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.4 | 2.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 8.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 6.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 10.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 3.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 9.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 2.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 5.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 8.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.4 | 3.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 7.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 2.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 2.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 0.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 3.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 2.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 9.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.3 | 4.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 3.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 1.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 18.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.3 | 4.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 1.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 1.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 4.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 21.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 1.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 8.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 5.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 4.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 2.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 2.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 1.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 0.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 3.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 1.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 2.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 3.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 6.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 2.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 4.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 6.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 4.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 1.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.7 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 5.8 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
0.1 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 6.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 2.0 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |